Trials / Unknown
UnknownNCT05212259
Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
A Randomized, Double-Blind, Placebo-controlled, Parallel Design Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 375 (estimated)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Double-Blind, Placebo-controlled, Parallel Design Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion \& Joint Discomfort in Healthy Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Collagen type II (40 mg/day) | 4 capsules per day |
| DRUG | Collagen type II (80mg/day) | 4 capsules per day |
| DRUG | Collagen type II (120 mg/day) | 4 capsules per day |
| DRUG | Glucosamine Hydrochloride with Chondroitin Sulphate (2700 mg) | 4 capsules per day |
| DRUG | Placebo | 4 capsules per day |
Timeline
- Start date
- 2022-10-10
- Primary completion
- 2023-09-15
- Completion
- 2023-09-15
- First posted
- 2022-01-28
- Last updated
- 2022-11-30
Locations
10 sites across 1 country: India
Source: ClinicalTrials.gov record NCT05212259. Inclusion in this directory is not an endorsement.